361 related articles for article (PubMed ID: 25629654)
1. Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States.
Foos V; Varol N; Curtis BH; Boye KS; Grant D; Palmer JL; McEwan P
J Med Econ; 2015 Jun; 18(6):420-32. PubMed ID: 25629654
[TBL] [Abstract][Full Text] [Related]
2. The economic impact of insulin-related hypoglycemia in Denmark: an analysis using the Local Impact of Hypoglycemia Tool.
Hoskins N; Tikkanen CK; Pedersen-Bjergaard U
J Med Econ; 2017 Apr; 20(4):363-370. PubMed ID: 27926814
[TBL] [Abstract][Full Text] [Related]
3. Economic impact of hypoglycemia among insulin-treated patients with diabetes.
Sussman M; Sierra JA; Garg S; Bode B; Friedman M; Gill M; Kaufman F; Vigersky R; Menzin J
J Med Econ; 2016 Nov; 19(11):1099-1106. PubMed ID: 27292016
[TBL] [Abstract][Full Text] [Related]
4. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.
Giorda CB; Rossi MC; Ozzello O; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Romeo F; Lucisano G; Nicolucci A;
Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523
[TBL] [Abstract][Full Text] [Related]
5. Economic impact of hypoglycemia on healthcare in Spain.
Brito-Sanfiel M; Diago-Cabezudo J; Calderon A
Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):649-60. PubMed ID: 21155698
[TBL] [Abstract][Full Text] [Related]
6. The impact of non-severe hypoglycemic events on work productivity and diabetes management.
Brod M; Christensen T; Thomsen TL; Bushnell DM
Value Health; 2011; 14(5):665-71. PubMed ID: 21839404
[TBL] [Abstract][Full Text] [Related]
7. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.
Willis WD; Diago-Cabezudo JI; Madec-Hily A; Aslam A
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):123-30. PubMed ID: 23402452
[TBL] [Abstract][Full Text] [Related]
8. Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries.
Geelhoed-Duijvestijn PH; Pedersen-Bjergaard U; Weitgasser R; Lahtela J; Jensen MM; Östenson CG
J Med Econ; 2013 Dec; 16(12):1453-61. PubMed ID: 24144009
[TBL] [Abstract][Full Text] [Related]
9. A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands.
de Groot S; Enters-Weijnen CF; Geelhoed-Duijvestijn PH; Kanters TA
BMJ Open; 2018 Mar; 8(3):e019864. PubMed ID: 29581204
[TBL] [Abstract][Full Text] [Related]
10. Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012).
Ward A; Alvarez P; Vo L; Martin S
J Med Econ; 2014 Mar; 17(3):176-83. PubMed ID: 24410011
[TBL] [Abstract][Full Text] [Related]
11. Cost of hypoglycemia in patients with Type 2 diabetes in Sweden.
Jönsson L; Bolinder B; Lundkvist J
Value Health; 2006; 9(3):193-8. PubMed ID: 16689714
[TBL] [Abstract][Full Text] [Related]
12. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
[TBL] [Abstract][Full Text] [Related]
13. Direct Health-Care Costs and Productivity Costs Associated With Hypoglycemia in Adults With Type 1 and Type 2 Diabetes Mellitus That Participated in the Canadian Hypoglycemia Assessment Tool Program.
O'Reilly DJ; Burke N; Tarride JE; Hahn J; Nurkanovic L
Can J Diabetes; 2018 Dec; 42(6):659-663. PubMed ID: 29885881
[TBL] [Abstract][Full Text] [Related]
14. Understanding the economic burden of nonsevere nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilization.
Brod M; Wolden M; Christensen T; Bushnell DM
Value Health; 2013 Dec; 16(8):1140-9. PubMed ID: 24326167
[TBL] [Abstract][Full Text] [Related]
15. Costs of diabetes and its complications in Poland.
Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
[TBL] [Abstract][Full Text] [Related]
16. Impact of the severity of hypoglycemia on health - Related quality of life, productivity, resource use, and costs among US patients with type 2 diabetes.
Pawaskar M; Iglay K; Witt EA; Engel SS; Rajpathak S
J Diabetes Complications; 2018 May; 32(5):451-457. PubMed ID: 29496365
[TBL] [Abstract][Full Text] [Related]
17. Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England.
Farmer AJ; Brockbank KJ; Keech ML; England EJ; Deakin CD
Diabet Med; 2012 Nov; 29(11):1447-50. PubMed ID: 22435781
[TBL] [Abstract][Full Text] [Related]
18. Health care resource utilization and costs during episodes of care for type 2 diabetes mellitus-related comorbidities.
Candrilli SD; Meyers JL; Boye K; Bae JP
J Diabetes Complications; 2015; 29(4):529-33. PubMed ID: 25660136
[TBL] [Abstract][Full Text] [Related]
19. The cost of managing severe hypoglycemic episodes in Type 2 diabetic patients.
Laires PA; Conceição J; Araújo F; Dores J; Silva C; Radican L; Nogueira A
Expert Rev Pharmacoecon Outcomes Res; 2016; 16(2):315-25. PubMed ID: 26844705
[TBL] [Abstract][Full Text] [Related]
20. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
